Reprogramming of arachidonate metabolism confers drug resistance to glioblastoma through Enhancing Mitochondrial Activity in Fatty Acid Oxidation
Yu-Ting Tsai(Taipei Medical University), Tsung‐I Hsu(National Health Research Institutes)
Cited by 0
Related Papers
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
|Journal of Biomedical Science|2022|56
ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade
|International Journal of Molecular Sciences|2019|43